• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

Encompass





Hi - I work for Encompass, and have for 8+ years. It's a privately owned company with investors. If anything, I'd expect them to take the company public on NYSE in the next few years.
 








It isn't a rumor anymore, that's what I call a nice big check for 750 million big ones. Welcome to the HealthSouth family! Guess it could be worse, you could have just been forcefully acquired by Kindred...